Scienture Holdings, Inc. (SCNX) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
SCIENTURE HOLDINGS, Inc is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the U.S.
the bull case· 2
+10.42%
net increase in shares held by the ten largest reporting managers
13fJun 30 '2616
managers reporting a position in thirteen f filings holding stakes
13fJun 30 '26the bear case· 2
7
managers whose positions together make up four fifths of reported value
13fJun 30 '264 of 11
largest reporting managers cut their stake in the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Mar 22 '27 report. Not a forecast, not advice.
High 0.33 at 5:45 am ET, low 0.31 at 2:30 pm ET.
Scienture Holdings, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
SCNX (Scienture Holdings, Inc.) has 1 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Scienture Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
tall tick = annual report · 1 on record
16 managers report a position worth $709,081 between them, and 7 of them hold 80% of it.